Canberra, Australia
+919405476170
+919405476170

Pariblieva 150mg Bulk Supply Australia | Oncology Medicine Distributor | Ernest Oncology

Global Exporter & Bulk Supplier: Pariblieva 150mg Tablet

🌍 Market Overview

Are you looking for a highly trusted international partner for advanced targeted oncology therapeutics? Ernest Oncology (a premier division of the Group of Ernest Pharmaceutical Pvt. Ltd.) is an established global exporter, bulk supplier, and distributor of Pariblieva 150mg Tablets.

Through our specialized, temperature-sensitive logistics networks, we fulfill high-volume procurement contracts for Olaparib 150mg to serve hospital groups, oncology clinics, and international pharmaceutical importers across the USA, UK, Australia, and South Africa.



🔬 Product Profile: Pariblieva 150mg Tablet

Pariblieva 150mg contains Olaparib, a powerful oral Poly (ADP-ribose) Polymerase (PARP) inhibitor. It is designed to disrupt the DNA repair mechanisms of cancer cells—specifically targeting those with $BRCA1$ or $BRCA2$ genetic mutations—leading to selective cell death through a mechanism known as synthetic lethality.

  • Active Ingredient: Olaparib (150mg)

  • Therapeutic Class: Antineoplastic / PARP Inhibitor

  • Primary Indications:

    • Advanced Ovarian Cancer: Used as a crucial maintenance therapy for BRCA-mutated advanced ovarian, fallopian tube, or primary peritoneal cancers.

    • gBRCAm HER2-Negative Breast Cancer: Formulated for patients with germline BRCA-mutated, HER2-negative metastatic breast cancer previously treated with chemotherapy.

    • Metastatic Pancreatic Cancer: Prescribed as a first-line maintenance treatment for germline BRCA-mutated metastatic pancreatic adenocarcinoma.

    • HRR Gene-Mutated Prostate Cancer: Utilized for metastatic castration-resistant prostate cancer (mCRPC) that has progressed following prior anti-androgen therapies.


📦 Logistics & Supply Capabilities

  • Compliant Sourcing Infrastructure: Sourced directly through validated pharmaceutical pathways operating in strict alignment with international GMP standards.

  • Streamlined Global Logistics: Specialized export procedures designed to navigate customs and regulatory frameworks smoothly within the USA, UK, Australia, and South Africa.

  • High-Volume B2B Fulfillment: Capable of consistently meeting the supply demands of major oncology clinic chains, healthcare ministries, and regional tenders.

  • Comprehensive Documentation Portfolios: Provision of verified Certificates of Analysis (COA), export invoicing, and temperature-controlled validation records.

PRESCRIPTION MEDICINE IS  : YES


⚠️ Disclaimer

Pariblieva 150mg Tablet is a highly potent, targeted prescription antineoplastic medication. It must only be administered under the direct guidance and supervision of a registered medical oncologist or specialized physician. This content is prepared exclusively for B2B trade, commercial purchasing, and pharmaceutical distribution networks; it does not replace professional medical advice.


📞 Contact Ernest Oncology — Global Medicine Exporter

🌐 Websites:

📧 Email: exports@ernestpharmaceuticals.com

📦 Business Type: Exporter | Bulk Supplier | Distributor

📲 WhatsApp: +91 93599 02383

🔗 WhatsApp Direct Link:https://wa.me/919359902383

 2026-05-15T11:40:04

Keywords